Compare CMRE & GRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CMRE | GRDN |
|---|---|---|
| Founded | 1974 | 2004 |
| Country | Monaco | United States |
| Employees | N/A | 3400 |
| Industry | Marine Transportation | Retail-Drug Stores and Proprietary Stores |
| Sector | Consumer Discretionary | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.1B |
| IPO Year | N/A | N/A |
| Metric | CMRE | GRDN |
|---|---|---|
| Price | $17.19 | $33.54 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $12.00 | ★ $33.33 |
| AVG Volume (30 Days) | ★ 462.9K | 178.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 2.73% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $19.50 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $5.55 | $117.77 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.63 | $17.78 |
| 52 Week High | $17.52 | $37.43 |
| Indicator | CMRE | GRDN |
|---|---|---|
| Relative Strength Index (RSI) | 56.04 | 52.10 |
| Support Level | $16.62 | $31.82 |
| Resistance Level | $17.52 | $33.04 |
| Average True Range (ATR) | 0.63 | 1.43 |
| MACD | 0.04 | -0.07 |
| Stochastic Oscillator | 68.05 | 52.93 |
Costamare Inc is an international owner and operator of containerships and dry bulk vessels. The company charter its containerships to the liner companies, providing transportation of containerized cargoes. It charter its dry bulk vessels to a wide variety of customers, providing transportation for dry bulk cargoes. The company's fleet of vessels includes Cosco Guangzhou, Cosco Ningbo, Cosco Yantian, Vantage, Valor, Valiant, Maersk Kobe, and among others. Costamare provides services to ocean carriers that demand a high standard of safety and reliability. It generates a majority of its revenue from the United States of America.
Guardian Pharmacy Services Inc is a differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing, and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs and BHFs. The operating segment derives its revenues through sales of pharmaceutical and medical products, and all revenues are derived solely in the United States.